Skip to Main Content
Accessibility Overview
JOIN A MEETING
HOST A MEETING
With Video Off
With Video On
HOST A MEETING WITH VIDEO
HOST A MEETING WITHOUT VIDEO
Sign In
Sign Up Free
webinar register page
The webinar has ended
Register to watch this recording on-demand
Facebook
Twitter
LinkedIn
Microsoft (Outlook)
Topic
Patent Claiming Strategies Do’s and Don’ts
Description
Patents give companies exclusive rights in their inventions – and when a competitor is encroaching on your market share, you can use your patents to stop them, although the outcome will depend on the strength of the patent claims. This session will discuss claiming strategies from a litigation perspective. We’ll provide the do’s and don’ts of claim drafting, so you can ensure your patent claims are strong, defensible and able to withstand scrutiny in litigation.
Attendees may earn up to 1.0 CLE credit for participating in this live webinar. Credit will not be granted for on-demand viewing. Cooley LLP is an approved provider, and will provide credit in CA, CO, IL, NY, PA and TX. Cooley LLP is a sponsor, and will apply for credit in OH, VA and WA. Credit in other jurisdictions may be available via reciprocity. If you have specific CLE credit questions, please contact Cooley’s licensing and compliance team.
Recording Duration
00:56:00
*
Required information
Loading
Register
Speakers
Sanya Sukduang
Partner
@
Cooley
Sanya has more than 20 years of experience litigating life sciences patent disputes, including Hatch-Waxman abbreviated new drug application (ANDA) challenges for brand drug manufacturers, biological products and medical devices. Drawing from extensive litigation experience, Sanya also advises clients on an array of pre-litigation and acquisition due diligence investigations, as well as strategic patent portfolio planning.
Jon Cousin
Associate
@
Cooley
Jon focuses on developing and executing worldwide patent strategies for life sciences and pharmaceutical companies. Jon concentrates on building patent portfolios to protect pharmaceutical products, which includes advising clients on portfolio creation and expansion, integrating patent and regulatory exclusivities, and advising on Orange Book listing strategies. He has a track record of success in identifying and executing strategies for late-stage inventions and navigating difficult patent issues. Notable patent portfolios Jon has worked on include Epidiolex, Copiktra, Farydak, Arikayce and Amrix.
×
Share via Email
All fields are required
Your Information
Send to
Message preview
Hi there, You are invited to a Zoom webinar. When: Feb 23, 2023 11:00 AM Pacific Time (US and Canada) Topic: Patent Claiming Strategies Do’s and Don’ts Register in advance for this webinar: https://cooley.zoom.us/webinar/register/WN_5epQ5hokR4SYiPLoNtfOQg Or an H.323/SIP room system: H.323: 162.255.37.11 (US West) 162.255.36.11 (US East) 221.122.88.195 (China) 115.114.131.7 (India Mumbai) 115.114.115.7 (India Hyderabad) 213.19.144.110 (Amsterdam Netherlands) 213.244.140.110 (Germany) 103.122.166.55 (Australia Sydney) 103.122.167.55 (Australia Melbourne) 209.9.211.110 (Hong Kong SAR) 149.137.40.110 (Singapore) 64.211.144.160 (Brazil) 149.137.68.253 (Mexico) 69.174.57.160 (Canada Toronto) 65.39.152.160 (Canada Vancouver) 207.226.132.110 (Japan Tokyo) 149.137.24.110 (Japan Osaka) Meeting ID: 963 9305 8625 SIP: 96393058625@zoomcrc.com After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Sanya Sukduang (Partner @Cooley) Sanya has more than 20 years of experience litigating life sciences patent disputes, including Hatch-Waxman abbreviated new drug application (ANDA) challenges for brand drug manufacturers, biological products and medical devices. Drawing from extensive litigation experience, Sanya also advises clients on an array of pre-litigation and acquisition due diligence investigations, as well as strategic patent portfolio planning. Jon Cousin (Associate @Cooley) Jon focuses on developing and executing worldwide patent strategies for life sciences and pharmaceutical companies. Jon concentrates on building patent portfolios to protect pharmaceutical products, which includes advising clients on portfolio creation and expansion, integrating patent and regulatory exclusivities, and advising on Orange Book listing strategies. He has a track record of success in identifying and executing strategies for late-stage inventions and navigating difficult patent issues. Notable patent portfolios Jon has worked on include Epidiolex, Copiktra, Farydak, Arikayce and Amrix.
×
Switch Time Zone
Time Zone:
(GMT-11:00) Midway Island, Samoa
(GMT-11:00) Pago Pago
(GMT-10:00) Hawaii
(GMT-8:00) Alaska
(GMT-8:00) Juneau
(GMT-7:00) Vancouver
(GMT-7:00) Pacific Time (US and Canada)
(GMT-7:00) Tijuana
(GMT-7:00) Arizona
(GMT-7:00) Mazatlan
(GMT-7:00) Yukon
(GMT-6:00) Edmonton
(GMT-6:00) Mountain Time (US and Canada)
(GMT-6:00) Saskatchewan
(GMT-6:00) Mexico City
(GMT-6:00) Guatemala
(GMT-6:00) El Salvador
(GMT-6:00) Managua
(GMT-6:00) Costa Rica
(GMT-6:00) Tegucigalpa
(GMT-6:00) Chihuahua
(GMT-6:00) Monterrey
(GMT-5:00) Winnipeg
(GMT-5:00) Central Time (US and Canada)
(GMT-5:00) Panama
(GMT-5:00) Bogota
(GMT-5:00) Lima
(GMT-5:00) Acre
(GMT-4:00) Montreal
(GMT-4:00) Eastern Time (US and Canada)
(GMT-4:00) Indiana (East)
(GMT-4:00) Puerto Rico
(GMT-4:00) Caracas
(GMT-4:00) La Paz
(GMT-4:00) Guyana
(GMT-3:00) Halifax
(GMT-3:00) Santiago
(GMT-3:00) Montevideo
(GMT-3:00) Recife
(GMT-3:00) Buenos Aires, Georgetown
(GMT-3:00) Greenland
(GMT-3:00) Sao Paulo
(GMT-3:00) Atlantic Time (Canada)
(GMT-2:30) Newfoundland and Labrador
(GMT-2:00) Fernando de Noronha
(GMT-1:00) Azores
(GMT-1:00) Cape Verde Islands
(GMT+0:00) Universal Time UTC
(GMT+0:00) Greenwich Mean Time
(GMT+0:00) Reykjavik
(GMT+0:00) Dublin
(GMT+0:00) London
(GMT+0:00) Lisbon
(GMT+0:00) Casablanca
(GMT+0:00) Nouakchott
(GMT+1:00) Belgrade, Bratislava, Ljubljana
(GMT+1:00) Sarajevo, Skopje, Zagreb
(GMT+1:00) Oslo
(GMT+1:00) Copenhagen
(GMT+1:00) Brussels
(GMT+1:00) Amsterdam, Berlin, Rome, Stockholm, Vienna
(GMT+1:00) Amsterdam
(GMT+1:00) Rome
(GMT+1:00) Stockholm
(GMT+1:00) Vienna
(GMT+1:00) Luxembourg
(GMT+1:00) Paris
(GMT+1:00) Zurich
(GMT+1:00) Madrid
(GMT+1:00) West Central Africa
(GMT+1:00) Algiers
(GMT+1:00) Tunis
(GMT+1:00) Warsaw
(GMT+1:00) Prague Bratislava
(GMT+1:00) Budapest
(GMT+2:00) Helsinki
(GMT+2:00) Harare, Pretoria
(GMT+2:00) Sofia
(GMT+2:00) Athens
(GMT+2:00) Bucharest
(GMT+2:00) Nicosia
(GMT+2:00) Beirut
(GMT+2:00) Tripoli
(GMT+2:00) Cairo
(GMT+2:00) Johannesburg
(GMT+2:00) Khartoum
(GMT+2:00) Kyiv
(GMT+2:00) Chisinau
(GMT+3:00) Jerusalem
(GMT+3:00) Nairobi
(GMT+3:00) Istanbul
(GMT+3:00) Damascus
(GMT+3:00) Amman
(GMT+3:00) Moscow
(GMT+3:00) Baghdad
(GMT+3:00) Kuwait
(GMT+3:00) Riyadh
(GMT+3:00) Bahrain
(GMT+3:00) Qatar
(GMT+3:00) Aden
(GMT+3:00) Djibouti
(GMT+3:00) Mogadishu
(GMT+3:00) Minsk
(GMT+3:30) Tehran
(GMT+4:00) Dubai
(GMT+4:00) Muscat
(GMT+4:00) Baku, Tbilisi, Yerevan
(GMT+4:30) Kabul
(GMT+5:00) Yekaterinburg
(GMT+5:00) Islamabad, Karachi, Tashkent
(GMT+5:30) India
(GMT+5:30) Mumbai, Kolkata, New Delhi
(GMT+5:30) Colombo
(GMT+5:45) Kathmandu
(GMT+6:00) Almaty
(GMT+6:00) Dacca
(GMT+6:00) Astana, Dhaka
(GMT+6:30) Rangoon
(GMT+7:00) Novosibirsk
(GMT+7:00) Krasnoyarsk
(GMT+7:00) Bangkok
(GMT+7:00) Vietnam
(GMT+7:00) Jakarta
(GMT+8:00) Irkutsk, Ulaanbaatar
(GMT+8:00) Beijing, Shanghai
(GMT+8:00) Hong Kong SAR
(GMT+8:00) Taipei
(GMT+8:00) Kuala Lumpur
(GMT+8:00) Singapore
(GMT+8:00) Perth
(GMT+9:00) Yakutsk
(GMT+9:00) Seoul
(GMT+9:00) Osaka, Sapporo, Tokyo
(GMT+9:30) Darwin
(GMT+10:00) Vladivostok
(GMT+10:00) Guam, Port Moresby
(GMT+10:00) Brisbane
(GMT+10:30) Adelaide
(GMT+11:00) Canberra, Melbourne, Sydney
(GMT+11:00) Hobart
(GMT+11:00) Magadan
(GMT+11:00) Solomon Islands
(GMT+11:00) New Caledonia
(GMT+11:00) Lord Howe IsIand
(GMT+12:00) Kamchatka
(GMT+12:00) Fiji Islands, Marshall Islands
(GMT+13:00) Auckland, Wellington
(GMT+13:00) Independent State of Samoa
×
Continue to PayPal
Click to Continue
×
×
Upcoming Meetings
Would you like to start this meeting?
Would you like to start one of these meetings?
View more...